Drugs / stem cell factor
stem cell factor
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00058045 | Aug 2002 → Nov 2003 | lymphoma | Roswell Park Cancer Institute | Completed | No outcome recorded |
| Phase 1 | NCT00005993 | May 1999 → Jul 2005 | breast cancer, lymphoma | Masonic Cancer Center, University of Minnesota | Terminated | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | stem cell factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00058045 ↗ |
| Known as | r-metHuSCF | “A Phase I Study Of Low-Dose Subcutaneous Interleukin 2 (IL-2) And Stem Cell Factor (r-metHuSCF) For Patients With AIDS And AIDS-Associated Malignancy” NCT00058045 ↗ |
| Known as | SCF | “stem cell factor (SCF)” NCT00005993 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human stem cell factor” NCT00005993 ↗ |
| Route | Subcutaneous | “stem cell factor SC three times a week” NCT00058045 ↗ |